PainChek Ltd ( (AU:PCK) ) has provided an update.
PainChek Ltd has announced the issuance of 27,549,501 new unquoted options, set to expire on March 24, 2026, with an exercise price of $0.05. This move is part of the company’s strategic financial operations, potentially impacting its market position and offering stakeholders an opportunity for future investment returns.
More about PainChek Ltd
PainChek Ltd operates in the healthcare technology industry, focusing on developing innovative pain assessment tools. The company is known for its digital health solutions that aim to improve pain management and patient care.
YTD Price Performance: 13.33%
Average Trading Volume: 1,024,895
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$58.06M
See more data about PCK stock on TipRanks’ Stock Analysis page.